Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inari Medical, Inc. - Common Stock (NQ:NARI)

79.97 UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inari Medical, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers Inari Medical (NASDAQ:NARI) stock... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:... 
Via Benzinga
News headline image
Earnings Scheduled For August 10, 2021 ↗
Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
News headline image
Inari Medical, Inc. (NARI) Q3 2021 Earnings Call Transcript ↗
NARI earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Recap: Inari Medical Q3 Earnings ↗
Inari Medical (NASDAQ:NARI) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:01 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
News headline image
3 Under-the-Radar COVID Stocks ↗
Some COVID-19 stocks are pretty famous. But other lesser-known names are flying high, too. 
Via The Motley Fool
News headline image
President And CEO Of Inari Medical Makes $2.4M Sale ↗
William Hoffman, President And CEO at Inari Medical (NASDAQ:NARI), made a large insider sell on October 7, according to a new SEC filing. What Happened: A Form 4 filing from the... 
Via Benzinga
Topics Regulatory Compliance
News headline image
Inari Medical Earnings Perspective: Return On Invested Capital ↗
Pulled from Benzinga Pro data, Inari Medical (NASDAQ:NARI) showed a loss in earnings since Q1, totaling $4.11 million. Sales, on the other hand, increased by 10.55% to $63.45... 
Via Benzinga
News headline image
Wall Street Thinks This Healthcare Stock Could Double Your Money in the Next Year ↗
Even the median estimate would be a 70% gain. 
Via The Motley Fool
News headline image
This Healthcare Company Just Shocked Its Investors ↗
The stock price is collapsing as a result. 
Via The Motley Fool
News headline image
66 Biggest Movers From Yesterday ↗
Gainers Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) shares jumped 50.5% to close at $20.74 on Wednesday. The company, last month, priced its IPO at $11 per share. Dyadic... 
Via Benzinga
Topics Initial Public Offering
News headline image
Inari Medical Plunged 15% After Mixed Q2 Earnings, Lifting FY21 Sales Guidance ↗
Inari Medical Inc's (NASDAQ: NARI) Q2 revenue was $63.5 million, more than doubled from $25.4 million in Q2 FY20, beating the consensus of $59.6 million. The growth... 
Via Benzinga
News headline image
Dow, S&P 500 Extend Highs After CPI Reading ↗
The Dow and S&P 500 both nabbed intraday record highs today, the Nasdaq slipped lower. 
Via Talk Markets
Topics Stocks
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers Dyadic International (NASDAQ:DYAI) stock increased by 28.96% to $4.63 during Wednesday's regular session. Trading volume for this security as of 12:30 EST is... 
Via Benzinga
News headline image
Why Shares of Inari Medical Are Falling Today ↗
Dollars outpaced procedures in the second quarter. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers CohBar (NASDAQ:CWBR) stock moved upwards by 68.21% to $2.17 during Wednesday's pre-market session. The company's market cap stands at $134.0 million. The... 
Via Benzinga
News headline image
22 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers CohBar, Inc. (NASDAQ: CWBR) shares rose 78.3% to $2.30 in pre-market trading after the company reported results from the Phase 1a/1b study of CB4211 under development for... 
Via Benzinga
News headline image
Forget Robinhood, These 3 Healthcare Stocks Are Better Buys ↗
Wait for pitches that are easy to hit before taking a swing. 
Via The Motley Fool
News headline image
Inari Medical, Inc. (NARI) Q2 2021 Earnings Call Transcript ↗
NARI earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
7 Stocks Moving In Tuesday's After-Hours Session ↗
Gainers Upstart (NASDAQ: UPST) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results and issued Q3 sales guidance above estimates. The... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers CohBar (NASDAQ:CWBR) shares incr... 
Via Benzinga
News headline image
Inari Medical: Q2 Earnings Insights ↗
Shares of Inari Medical (NASDAQ:NARI) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 143.75% year over... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
News headline image
3 Things I'm Looking For in Inari Medical's Earnings ↗
What does normal look like? 
Via The Motley Fool
News headline image
3 COVID Stocks That Could Soar Higher ↗
Here's why Pfizer, Inari Medical, and Novavax shares might be more valuable in 2021. 
Via The Motley Fool
Topics Economy
News headline image
2 Best Buys of the Nasdaq Right Now ↗
The overall market might be expensive, but these stocks aren't. 
Via The Motley Fool
Topics Stocks
News headline image
Investors Face New Risks In Stock Market Forecast For The Next Six Months ↗
Stocks are at a crossroads, with new risks taking shape even as the market hits new highs. 
Via Investor's Business Daily
Topics Economy
News headline image
Inari Medical: Return On Capital Employed Insights ↗
Looking at Q1, Inari Medical (NASDAQ:NARI) earned $7.71 million, a 10.25% increase from the preceding quarter. Inari Medical also posted a total of $57.40 million in sales, a 18.... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.